GLUCAGEN 1 mg/ml, powder and solvent for solution for injection bottle, 1 ml
Active ingredients: Glucagon hydrochloride, GLUCAGON HUMAIN BIOGÉNÉTIQUE
Commercialized according to BDPMDispensing in France: Prescription only
Powder and solvent for solution for injectionbottle, 1 mlintramusculaire;intraveineuse;sous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- GLUCAGEN 1 mg/ml, poudre et solvant pour solution injectable
- Pharmaceutical form
- poudre et solvant pour solution injectable
- Route of administration
- intramusculaire;intraveineuse;sous-cutanée
- Presentation description
- 1 flacon(s) en verre - 1 flacon(s) en verre de 1 ml
- Marketing authorisation holder
- NOVO NORDISK
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 31 Oct 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60084049CIP73359055CIP133400933590550Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE GLUCAGONpoudre | — | SA |
| GLUCAGON HUMAIN BIOGÉNÉTIQUEpoudre | 1 mg · un flacon | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.